Both in Pharmaceuticals
Immix Biopharma vs Olema Pharmaceuticals
Over the past year IMMX returned +406.7% and OLMA returned −10.5%; their daily moves had a correlation of 0.10.
IMMX +406.7% OLMA −10.5%Growth of $1, one year, split-adjusted
| Metric | IMMX | OLMA |
|---|---|---|
| Price | $10.54 | $8.54 |
| Market cap | $754.0M | $747.2M |
| Today | −8.11% | −0.81% |
| 1 month | −24.4% | −16.8% |
| 6 months | +22.8% | −36.4% |
| Year to date | +101.5% | −65.8% |
| 1 year | +406.7% | −10.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $232.1M | $458.1M |
| Dividend yield | — | — |
| Volatility (60d) | 83.7% | 52.8% |
| Short % of float | 20.2% | 27.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).